Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease

ConclusionThis is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.

Dexmedetomidine has been reported safe in paediatric patients. In this report, we communicate a case of paroxysmal supraventricular tachycardia (PSVT) after DEX withdrawal in a four years‐old girl with no former history of heart disease.

Source: Journal of Clinical Pharmacy and Therapeutics - May 27, 2017 Category: Drugs & Pharmacology Authors: J. Carlos Flores ‐González, Ana Estalella‐Mendoza, Alfonso M. Lechuga‐Sancho, Arturo Hernández‐González, Fernando Rubio‐Quiñones, Patricia Rodríguez‐Campoy, Mónica Saldaña‐Valderas Tags: CASE REPORT Source Type: research